Navigation Links
Boosting vitamin D could slow progression, reduce severity of multiple sclerosis
Date:1/20/2014

Boston, MA For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare. The findings suggest that patients in the early stages of MS could stave off disease symptoms by increasing their vitamin D intake.

"Because low vitamin D levels are common and can be easily and safely increased by oral supplementation, these findings may contribute to better outcomes for many MS patients," said lead author Alberto Ascherio, professor of epidemiology and nutrition at HSPH.

The study will appear online January 20, 2014 in JAMA Neurology.

MS is a central nervous system disease that causes problems with muscle control and strength, vision, balance, feeling, and thinking. It's estimated by the World Health Organization that roughly 2.5 million people in the world have MS.

Previous research indicated a connection between low levels of vitamin D and risk of developing MS or having MS symptoms worsen, but those studies included patients with longstanding MS whose vitamin D levels could partly be a consequence, not a predictor, of disease severity. The new study looked at vitamin D levels among patients at the time of their first symptoms of the disease.

Researchers analyzed data from 465 MS patients from 18 European countries, Israel, and Canada who enrolled in 2002 and 2003 in the BENEFIT (Betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment) trial, which was aimed at comparing the effectiveness of early versus late interferon beta-1b in treating the disease. The scientists looked at how the patients' vitamin D levelswhich were measured at the onset of their symptoms and at regular intervals over a 24-month periodcorrelated with their disease symptoms and progression over a period of five years.

They found that early-stage MS patients who had adequate levels of vitamin D had a 57% lower rate of new brain lesions, a 57% lower relapse rate, and a 25% lower yearly increase in lesion volume than those with lower levels of vitamin D. Loss in brain volume, which is an important predictor of disability, was also lower among patients with adequate vitamin D levels. The results suggest that vitamin D has a strong protective effect on the disease process underlying MS, and underscore the importance of correcting vitamin D insufficiency, which is widespread in Europe and the U.S., the researchers said.

"The benefits of vitamin D appeared to be additive to those of interferon beta-1b, a drug that is very effective in reducing MS activity. The findings of our study indicate that identifying and correcting vitamin D insufficiency should become part of the standard of care for newly diagnosed MS patients," said Ascherio.


'/>"/>

Contact: Karen Feldscher
kfeldsch@hsph.harvard.edu
614-432-8439
Harvard School of Public Health
Source:Eurekalert

Related biology news :

1. New Brain Supplement Focus Boost Launches, Boosting Alertness, Memory and Focus
2. Immune-boosting colorectal cancer drug shows promise
3. Plant scientists at CSHL demonstrate new means of boosting maize yields
4. New American Chemical Society podcast: Boosting the sensitivity of airport security screening
5. Boosting galactan sugars could boost biofuel production
6. New health-economic model shows benefits of boosting dietary calcium intake
7. Boosting blood system protein complex protects against radiation toxicity
8. Vitamin D supplements reduce pain in fibromyalgia sufferers
9. Higher vitamin D levels associated with better cognition and mood in PD patients
10. Most clinical studies on vitamins flawed by poor methodology
11. HCG Injections and B12 shots now in stock at US Vitamin Injections Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... ... June 18, 2020 , ... Biosero ... Data Decisions,” for pharmaceutical and biotech executives, laboratory managers, scientists, researchers and ... instruments and laboratory equipment from dozens of manufacturers into their lab. , ...
(Date:6/13/2020)... ... June 11, 2020 , ... ... announces a significant expansion of its forensic genealogy team. Bode’s Forensic Genealogy ... through proven forensic genealogy and DNA analysis methods. The team has added experienced ...
(Date:6/11/2020)... SEABROOK, N.H. (PRWEB) , ... June 09, 2020 , ... ... integrator of custom industrial automation and IT solutions for the life sciences industry, is ... President of Business Development working out of the company’s Seabrook, New Hampshire office. ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... announced that the launch of a new clinical diagnostics immuno-oncology service, ... tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... facilitate access to unique lab-made bioresearch materials, today announced the availability of the ... Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and ...
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace ... is to join forces to radically prolong life and find a way (medicine or ... period. This project was supported by various scientists from all over the world, doctors, ...
(Date:6/3/2020)... (PRWEB) , ... June 03, 2020 , ... ... to highlight various applications of biofeedback. In the next installment, Dr. Inna Khazan ... practice whereby individuals learn to bring their attention to the feelings, thoughts, and ...
Breaking Biology Technology: